J
Jens Atzrodt
Researcher at Aventis Pharma
Publications - 19
Citations - 1297
Jens Atzrodt is an academic researcher from Aventis Pharma. The author has contributed to research in topics: Catalysis & Deuterium. The author has an hindex of 14, co-authored 19 publications receiving 845 citations.
Papers
More filters
Journal ArticleDOI
Deuterium- and Tritium-Labelled Compounds: Applications in the Life Sciences
TL;DR: Advances in the application of hydrogen isotopes in the life sciences are described and 3 H, in particular, has seen an increase in utilization, especially in pharmaceutical drug discovery.
Journal ArticleDOI
C-H Functionalisation for Hydrogen Isotope Exchange.
TL;DR: This Review describes recent advances in synthetic C-H functionalisation for hydrogen isotope exchange in the physical and life sciences.
Journal ArticleDOI
Die Renaissance des H/D-Austausches
TL;DR: In this paper, the steigende Nachfrage nach stabil isotopenmarkierten Verbindungen fuhrt zu einem verstarkten Interesse an H/D-Austauschreaktionen an Kohlenstoffatomen.
Journal ArticleDOI
Deuterium- und tritiummarkierte Verbindungen: Anwendungen in den modernen Biowissenschaften
TL;DR: The wide range of applications involving hydrogen isotopes in drug discovery and beyond dictates that their selective and efficient installation continues to present an important and continuing challenge to synthetic chemists as discussed by the authors.
Journal ArticleDOI
Iridium-catalysed ortho-H/D and -H/T exchange under basic conditions: C–H activation of unprotected tetrazoles
William J. Kerr,David M. Lindsay,Marc Reid,Jens Atzrodt,Volker Derdau,Patrick Rojahn,Remo Weck +6 more
TL;DR: A new base-assisted protocol for iridium(i) hydrogen isotope exchange catalysis allows access to ortho-deuterated and tritiated tetrazoles, including the tetrazole-containing pharmaceutical, Valsartan.